Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript

Arcadia Biosciences, Inc (NASDAQ:RKDA) Q4 2024 Results Conference Call March 20, 2025 4:30 PM ET

Company Participants

Mark Kawakami – Chief Financial Officer
T.J. Schaefer – President & Chief Executive Officer

Conference Call Participants

Ben Klieve – Lake Street Capital Markets

Operator

Good afternoon, and welcome to Arcadia Biosciences Fourth Quarter and Full Year 2024 Financial Results and Business Highlights Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to Mark Kawakami, Chief Financial Officer at Arcadia. Please go ahead.

Mark Kawakami

Thank you, and good afternoon. Joining me on the call today is T.J. Schaefer, Arcadia’s President and Chief Executive Officer. This call is being webcast and you can refer to the company’s press release at arcadiabio.com.

Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied today. You can review the company’s safe harbor language in our most recently filed 10-K.

With that, I’ll now turn the call over to T.J.

T.J. Schaefer

Good afternoon, and thank you for joining us today to discuss our 2024 fourth quarter and full year financial results. The year 2024 represented the culmination of a multiyear plan to put Arcadia on a path to profitability, and I am extremely pleased with the progress we have made. Over the last 2 years, we have exited underperforming Body Care brands in an effort to simplify our business and focus our resources on our most promising brands.

In mid-2024, we seized on an opportunity to monetize a portion